Chamber and committees

On 15 June 2021, the Advisory Sub-group for Education and Children’s Issues provided advice on whether groups of parents should be permitted to attend ELC settings for outdoor events such as nursery graduations. Their advice was that groups of parents and carers should not attend end-of-year events in Early Learning and Childcare settings, whether indoors or outdoors. This was a carefully considered decision that weighed up all of the risks involved to safeguard public health.

In relation to the Fan Zone Scottish Ministers have undertaken significant consultation with public health officials and clinicians who have provided advice throughout development of Glasgow City Council’s proposal. The Fan Zone provides an outdoor, highly regulated space for fans to watch the tournament. Although there will be up to 3,000 people in attendance per session, this is in a large, outdoor space with normal capacity for up to 80,000 people. Necessary physical distancing and hygiene measures are in place. In addition, there is comprehensive stewarding, cleaning and contact tracing provisions in place and everyone attending are encouraged to take a lateral flow test prior to the event. Rapid lateral flow test kits are being mailed to all visitors to the Glasgow Fan Zone. This move is part of a series of measures to help reduce the risk of transmission before and after the event.

The Scottish Government continue to meet and work collaboratively with the recognised representative body for community pharmacy contractors in Scotland, Community Pharmacy Scotland.

Discussions have included the pharmacy networks response to the COVID-19 pandemic, additional support provided to the community pharmacy teams in providing a safe working environment and access to mental health and wellbeing support. The delivery of current and development of future pharmaceutical care service to support the NHS recovery from the pandemic and the impact of the pandemic to the financial sustainability of pharmacy network and the Scottish Drug Tariff.

Officials have also met with NHS Board Directors of Pharmacy to discuss the provision of pharmaceutical care services.

The Complex Pelvic Mesh Removal Service in NHS Greater Glasgow and Clyde (NHS GGC) is managed through a Service Level Agreement with NHS National Services Scotland (NSS). The service reports to NSS on a number of indicators, including patient experience data, any significant adverse events and waiting times. This information will be used for comparison across the UK specialist centres, and will support quality assurance and improvement.

In addition, NHS Scotland is taking part in the development of a UK-wide Pelvic Floor Registry, which will aim to monitor and improve patient safety. It will record surgical mesh implants, and related medical devices, given to patients, and the organisations and surgeons that have carried out the procedures.

The registry will also collect information about patients that receive alternative procedures that do not include a medical device or implant so that outcomes can be compared and complications can be understood.

The main aim of the registry is to improve patient safety. It will mean that patients can be traced in the event of a product recall or safety concern relating to a specific type of implant or treatment. Outcomes data collected by the registry will also be used to improve procedures offered to future patients.

NHS Scotland will pilot the registry in Scotland and the NHS GGC will be involved.

I refer the member to the answer to question S6W-00790 on‎ 13 July 2021. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

This information is not held centrally. It is the responsibility of territorial Health Boards to ensure there is adequate provision of NHS Pharmaceutical Care Services, working with community pharmacy contractors listed on the Boards Pharmaceutical List.

The National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009 set out the responsibilities for community pharmacy contractors to notify Health Boards when there are instances in which the contractor is unable to provide those NHS services.

Please note that data regarding the number of COVID-19 vaccination sessions delivered are held by individual NHS Health Boards.

It is important to be clear that there has been no change in the Scottish Government’s policy on the remuneration arrangements for independent contractors or those working within a primary care settings participation in the COVID Vaccination programme.

The Scottish Government wrote to Health Boards on 5 March 2021 to ensure that the original policy was being properly implemented. Following this, a number of Boards adapted their approach.

The Scottish Government hold regular meetings with Community Pharmacy Scotland, the recognised representative body of community pharmacy contractors in Scotland as set out in the National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009. In response to the COVID-19 pandemic and over the last 12 months, Scottish Government officials and Community Pharmacy Scotland representatives have met on a bi-weekly cycle to discuss a range of issues related to the community pharmacy network in Scotland.

In the last 12 months, Scottish Government officials have met with the Guild of Healthcare Pharmacists on two occasions and the Pharmacists Defence Association on two occasions.

528 applications have been approved and when the next payment is made in July, £534,359 will have been paid from the Scottish Government mesh fund. This includes fees paid to GPs for providing proof of complications.

The Transvaginal Mesh Removal (Cost Reimbursement) (Scotland) Bill was introduced on 23 June 2021. It is published on the Scottish Parliament website .